Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

  • Condition: Giant Cell Lesions
  • Journal: Birth defects research
  • Treatment Used: Surgery and Interferon Alpha-2a Therapy
  • Number of Patients: 1
  • Published —
In this study, researchers sought to determine the best treatment for giant cell lesions due to Noonan syndrome.
  • Condition: Noonan Syndrome (NS)
  • Journal: Pediatric endocrinology reviews : PER
  • Treatment Used: Recombinant Growth Hormone (rhGH)
  • Number of Patients: 0
  • Published —
This review of the literature examined recombinant growth hormone (rhGH) therapy in the treatment of Noonan syndrome (NS), a genetic disorder.
Clinical Trial
  • Status: Recruiting
  • Participants: 20000
  • Start Date: July 2010
Coordination of Rare Diseases at Sanford
Clinical Trial
  • Status: Active, not recruiting
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: February 26, 2018
Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)